Jon Snodgres, Chief Financial Officer at REPLIGEN CORP (RGEN), sold 1,320 shares at $140.43 ($185K) on 2020-05-15, disclosed to the SEC on 2020-05-19.
Open-market sale of $185k RGEN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $140.43 | 660 | $93K | 50.0% |
| 2 | $140.43 | 660 | $93K | 50.0% |
| Total | $140.43 avg | 1,320 | $185K | 100% |
| Filing → |
| RGEN | SELL | 2022-08-02 | $440K | — | Filing → |
| RGEN | SELL | 2021-05-18 | $81K | — | Filing → |
| RGEN | SELL | 2021-03-08 | $797K | — | Filing → |